NYBC Ventures: Innovating blood-related fields and cellular therapies with a $50M fund.
Founded
2021
Location
Boston, MA, US
NYBC Ventures was founded by the New York Blood Center with a $50 million investment to accelerate innovation in blood-related fields and cellular therapies. The core mission is to improve patients' lives by advancing therapeutics, enabling platforms, and technologies, and fostering collaborations. The venture fund focuses on investing in therapeutics, devices, and innovative technologies within cell therapy, transfusion medicine, benign hematology, and infectious disease sectors.
Notable affiliated people include leaders from the New York Blood Center, who bring extensive expertise in medical and technological innovation. Key achievements include strategic investments that have propelled advancements in blood and cellular therapies. The overall impact of NYBC Ventures is significant, as it drives both humanitarian and fiscal returns by addressing critical challenges in healthcare and enhancing the New York Blood Center's mission-oriented innovation.
